Sabirnetug | m-entrepreneurship.com

Product Name :
Sabirnetug

Search keywords :
Sabirnetug

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Anti-Amyloid Beta Oligomer

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Northwestern University

Active Company_Name :
Acumen Pharmaceuticals Inc

Active Indication_Name:
Alzheimer Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CDT1 Antibody
VCAM1 Antibody
AKT1/AKT2/AKT3 Antibody (YA635): AKT Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 56 kDa, targeting to AKT. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat, Hamster.

Author: Betaine hydrochloride

Related Posts